Edwards Lifesciences Corp Annual Operating Income (Loss) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Edwards Lifesciences Corp quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
  • Edwards Lifesciences Corp Operating Income (Loss) for the quarter ending September 30, 2024 was $351M, a 4.18% decline year-over-year.
  • Edwards Lifesciences Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was $1.62B, a 10.8% increase year-over-year.
  • Edwards Lifesciences Corp annual Operating Income (Loss) for 2023 was $1.53B, a 12.3% decline from 2022.
  • Edwards Lifesciences Corp annual Operating Income (Loss) for 2022 was $1.75B, a 3.44% increase from 2021.
  • Edwards Lifesciences Corp annual Operating Income (Loss) for 2021 was $1.69B, a 88.3% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.53B -$214M -12.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-12
2022 $1.75B +$58.2M +3.44% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-12
2021 $1.69B +$793M +88.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-12
2020 $898M -$249M -21.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-13
2019 $1.15B +$399M +53.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-14
2018 $748M -$341M -31.3% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-12
2017 $1.09B +$338M +45% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-14
2016 $751M Jan 1, 2016 Dec 31, 2016 10-K 2019-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.